⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 29, 2016JAMA Oncology

Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States

Jim C. Hu Paul L. Nguyen Jialin Mao Joshua A. Halpern Jonathan E. Shoag Jason D. Wright Art Sedrakyan

View at Publisher

Ask AI

Bookmark

Share

Abstract

This population-based study assesses the effect of the decline in prostate-specific antigen screening and incidence on prostate cancer presentation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hu et al. (2016) studied this question.

synapsesocial.com/papers/6a74a41a5be14952a7f543d0 https://doi.org/10.1001/jamaoncol.2016.5465

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Neoadjuvant Stereotactic Ablative Radiotherapy Before Inferior Vena Cava Thrombectomy for Renal Cell CarcinomaJAMA Oncology · Thu,
2Nivolumab-Ipilimumab for Localized Microsatellite Instability–High Gastric/Gastroesophageal Junction AdenocarcinomaJAMA Oncology · Thu,
3Beyond Tumor Size, Toward Meaningful Patient Outcomes—Resisting RECISTJAMA Oncology · Thu,
4Disitamab Vedotin Plus Tislelizumab in Transurethrally Unresectable, ERBB2 -Positive, Non–Muscle-Invasive Bladder CancerJAMA Oncology · Thu,
5Rethinking Treatment Intensification in Poorly Chemosensitive Ovarian CancerJAMA Oncology · Thu,

More from JAMA Oncology

Immune Checkpoint Inhibitor–Based Downstaging Therapy for Hepatocellular CarcinomaThu,
Rethinking Value in Cancer Care in the USThu,
Disparities in Cancer Incidence by Sex and Associated Lifestyle Factors and Health ConditionsThu,
Patient Reported Outcomes and Financial Toxicity in Head and Neck CancerThu,
Chemotherapy and Surgical Outcomes for Ovarian Metastases From Colorectal CancerThu,